These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Diagnosis of endolymphatic hydrops using low frequency modulated distortion product otoacoustic emissions]. Hirschfelder A, Gossow-Müller-Hohenstein E, Hensel J, Scholz G, Mrowinski D. HNO; 2005 Jul; 53(7):612-7. PubMed ID: 15565422 [Abstract] [Full Text] [Related]
6. Spontaneous otoacoustic emissions in humans with endolymphatic hydrops. Haginomori SI, Makimoto K, Tanaka H, Araki M, Takenaka H. Laryngoscope; 2001 Jan; 111(1):96-101. PubMed ID: 11192908 [Abstract] [Full Text] [Related]
7. Early diagnosis of endolymphatic hydrops with distortion. Product otoacoustic emissions. Magliulo G, Cianfrone G, Di Cello P, Tersigni A. An Otorrinolaringol Ibero Am; 2004 Jan; 31(2):173-89. PubMed ID: 15185614 [Abstract] [Full Text] [Related]
8. Otoacoustic emissions, ear fullness and tinnitus in the recovery course of sudden deafness. Ishida IM, Sugiura M, Teranishi M, Katayama N, Nakashima T. Auris Nasus Larynx; 2008 Mar; 35(1):41-6. PubMed ID: 17904320 [Abstract] [Full Text] [Related]
10. Does 'cochlear Ménière's disease' exist? An electrocochleographic and audiometric study. Claes GM, De Valck CF, Van de Heyning P, Wuyts FL. Audiol Neurootol; 2013 Mar; 18(1):63-70. PubMed ID: 23128402 [Abstract] [Full Text] [Related]
11. Evaluation of low-frequency biasing as a diagnostic tool in Menière patients. Hof-Duin NJ, Wit HP. Hear Res; 2007 Sep; 231(1-2):84-9. PubMed ID: 17658231 [Abstract] [Full Text] [Related]
12. Semi-quantitative evaluation of endolymphatic hydrops by bilateral intratympanic gadolinium-based contrast agent (GBCA) administration with MRI for Meniere's disease. Fukuoka H, Tsukada K, Miyagawa M, Oguchi T, Takumi Y, Sugiura M, Ueda H, Kadoya M, Usami S. Acta Otolaryngol; 2010 Sep; 130(1):10-6. PubMed ID: 19363714 [Abstract] [Full Text] [Related]
13. Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Junicho M, Aso S, Fujisaka M, Watanabe Y. Acta Otolaryngol; 2008 Mar; 128(3):304-8. PubMed ID: 18274917 [Abstract] [Full Text] [Related]
14. Brain and inner-ear fluid homeostasis, cochleovestibular-type tinnitus, and secondary endolymphatic hydrops. Shulman A, Goldstein B. Int Tinnitus J; 2006 Mar; 12(1):75-81. PubMed ID: 17147045 [Abstract] [Full Text] [Related]
15. A Comparison of Distortion Product Otoacoustic Emission Properties in Ménière's Disease Patients and Normal-Hearing Participants. Drexl M, Krause E, Gürkov R. Ear Hear; 2018 Mar; 39(1):42-47. PubMed ID: 28671918 [Abstract] [Full Text] [Related]
16. Clinical application of transiently evoked otoacoustic emissions after glycerol administration for diagnosis of sensorineural hearing loss. Inoue Y, Kanzaki J, O-Uchi T, Ogawa K, Ogata A, Yoshihara S, Satoh Y. Auris Nasus Larynx; 1997 Apr; 24(2):143-9. PubMed ID: 9134136 [Abstract] [Full Text] [Related]
17. Evaluation of cochlear function in an acute endolymphatic hydrops model in the guinea pig by measuring low-level DPOAEs. Valk WL, Wit HP, Albers FW. Hear Res; 2004 Jun; 192(1-2):47-56. PubMed ID: 15157962 [Abstract] [Full Text] [Related]
18. Cochlear microphonics in Ménière's disease. Ge NN, Shea JJ, Orchik DJ. Am J Otol; 1997 Jan; 18(1):58-66. PubMed ID: 8989953 [Abstract] [Full Text] [Related]